LIXTE Biotechnology
LIXTE Biotechnology changes directorMultiExec Change12d ago
LIXTE Biotechnology LIXT
TrackingVerified·Jun 8, 2026LIXTE Biotechnology
🇺🇸US
ETH Holdings
301
USD Value
$560.1K
Avg Buy Price
$2,953.00
Analyst metrics
Position
Current holdings
301 ETH
Last tracked event
November 24, 2025
ETH peers
ETH
301
BMNR
5,770,038
SBET
886,725
BTBT
162,081
BTCS
57,607
LIXTE Biotechnology has only filed a handful of per-event ETH disclosures so far. The chart needs more data points to read meaningfully — every new SEC filing lands within 5 minutes and gets stitched in automatically.
Data coverage
300 ETH itemized across 1 disclosed move
301 ETH current holdings · per third-party tracker
Treasury Activity covers ≥95% of the reported position. Every individual move below is a disclosed event.
Treasury Activity (1)
| Date | Source | ETH | USD | Price/ETH | Sentiment | |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | SEC | +300 | $885.9K | $2,953.06 | 56 Neutral |
Compare LIXT against
Data provenance
Last verified: Jul 14, 2026Sources
- The company's SEC filings
- Company press releases and investor communications
- Earnings call transcripts
Known limitations
Delays between when a filing is published and when we read it can introduce up to ~5 minutes of latency in the purchase feed. Filings amended after the fact may briefly show conflicting values until we reconcile.
Spot an error? See the full data coverage policy.